KaloBios Pharmaceuticals settlements

KaloBios Pharmaceuticals is the subject of a securities class action settlement covering investors who purchased or acquired the company's common stock during a narrow two-week window in November and December 2015. The settlement resolved claims related to that trading period and provided a total aggregate gross recovery of $3,000,000.00 cash plus $254,722.73 in proceeds from the sale of 300,000 shares. The claim deadline for this settlement has passed, but the verified record remains here for reference.

Check what you may be owed Free · takes 20 seconds

Published directory

1 published record

Proof required

Antitrust

Kalobios

KaloBios Pharmaceuticals investors reached a securities settlement with defendant Martin Shkreli, resolving claims from shareholders who bought or acquired KaloBios stock between November 19, 2015 and December 16, 2015. The recovery totaled $3,000,000 in cash plus $254,722.73 in proceeds from stock sold under an earlier partial settlement. The claim filing window has closed.

Claim window closed Evidence-verified

Related companies with published settlements

Share this collection — free to repost with a link back.

There may be money with your name on it.

Free to browse and track. Every record shows its official-evidence status — and you open the official claim form yourself.

Check what you may be owed Browse all settlements